Skip to Main Content

Paper Details

Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency.
J Allergy Clin Immunol Pract
13
2022
Author NameAffiliation
Vivek NaranbhaiHarvard Medical School, Mass Dana-Farber Cancer Institute
Hang LeeHarvard Medical School
  • 1 - 2

Datasets

Release 1.2